The effects of chronic buprenorphine on intake of heroin and cocaine in rats and its effects on nucleus accumbens dopamine levels during self-administration

Psychopharmacology

Volumn 188, Issue 1, 2006, Pages 28-41

  Sorge, Robert E ^a   Stewart, Jane ^a  

^a and Applied Physiology   (Canada)

Author keywords

Addiction; Buprenorphine; Cocaine; Cues; Dopamine; Heroin; Microdialysis; Nucleus accumbens; Reinforcement; Self administration

Indexed keywords

BUPRENORPHINE; COCAINE; DIAMORPHINE; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRAIN LEVEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INFUSION; DRUG MECHANISM; DRUG RESPONSE; DRUG SELF ADMINISTRATION; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VIVO STUDY; LATENT PERIOD; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; OSMOSIS; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BUPRENORPHINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; CONDITIONING, OPERANT; DOPAMINE; HEROIN; MALE; MICRODIALYSIS; NARCOTIC ANTAGONISTS; NARCOTICS; NUCLEUS ACCUMBENS; RATS; RATS, LONG-EVANS; SELF ADMINISTRATION; TIME FACTORS;

EID: 33747584364     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0485-1     Document Type: Article

References (45)

1. Allen RM, Carelli RM, Dykstra LA, Suchey TL, Everett CV (2005) Effects of the competitive N-Methyl-D-aspartate receptor antagonist, LY235959 [(-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid], on responding for cocaine under both fixed and progressive ratio schedules of reinforcement. J Pharmacol Exp Ther 315:449-457
2. Baptista MA, Martin-Fardon R, Weiss F (2004) Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer. J Neurosci 24:4723-4727
3. Bickel WK, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR, Johnson RE (1988) Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans. J Pharmacol Exp Ther 247:47-53
4. Bossert JM, Busch RF, Gray SM (2005) The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking. Neuroreport 16:1013-1016
5. Britt MD, Wise RA (1983) Ventral tegmental site of opiate reward: antagonism by a hydrophilic opiate receptor blocker. Brain Res 258:105-108
6. Brown EE, Finlay JM, Wong JT, Damsma G, Fibiger HC (1991) Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse. J Pharmacol Exp Ther 256:119-126
7. Carroll ME, Lac ST (1992) Effects of buprenorphine on self-administration of cocaine and a nondrug reinforcer in rats. Psychopharmacology 106:439-446
8. Comer SD, Walker EA, Collins ED (2005) Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in hero-independent volunteers. Psychopharmacology 181:664-675
9. Compton PA, Ling W, Charuvastra VC, Wesson DR (1995) Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence. J Addict Dis 14:97-114
10. Devine DP, Wise RA (1994) Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci 14:1978-1984
11. Filibeck U, Castellano C, Oliverio A (1981) Differential effects of opiate agonists-antagonists on morphine-induced hyperexcitability and analgesia in mice. Psychopharmacology 73:134-136
12. Gratton A, Wise RA (1994) Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. J Neurosci 14:4130-4146
13. Greenwald MK, Schuh KJ, Hopper JA, Schuster CR, Johanson CE (2002) Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans. Psychopharmacology (Berl) 160(4):344-352
14. Greenwald MK, Johanson CE, Moody DE, Woods JH, Kilbourn MR, Koeppe RA, Schuster CR, Zubieta JK (2003) Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology 28:2000-2009
15. Hemby SE, Co C, Dworkin SI, Smith JE (1999) Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine/heroin combinations (Speedball) in rats. J Pharmacol Exp Ther 288:274-280
16. Huang NK, Tseng CJ, Wong CS, Tung CS (1997) Effects of acute and chronic morphine on DOPAC and glutamate at subcortical DA terminals in awake rats. Pharmacol Biochem Behav 56:363-371
17. Ito R, Dalley JW, Howes SR, Robbins TW, Everitt BJ (2000) Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J Neurosci 20:7489-7495
18. Kosten TR, Gawin FH, Rounsaville BJ, Kleber HD (1986) Cocaine abuse among opioid addicts: demographic and diagnostic factors in treatment. Am J Drug Alcohol Abuse 12:1-16
19. Kunko PM, French D, Izenwasser S (1998) Alterations in locomotor activity during chronic cocaine administration: effect on dopamine receptors and interaction with opioids. J Pharmacol Exp Ther 285:277-284
20. Leander JD (1983) Opioid agonist and antagonist behavioural effects of buprenorphine. Br J Pharmacol 78:607-615
21. Leri F, Stewart J (2001) Drug-induced reinstatement to heroin and cocaine seeking: a rodent model of relapse in polydrug use. Exp Clin Psychopharmacol 9:297-306
22. Leri F, Tremblay A, Sorge RE, Stewart J (2004) Methadone maintenance reduces heroin- and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of polydrug use. Neuropsychopharmacology 29:1312-1320
23. Lorrain DS, Arnold GM, Vezina P (2000) Previous exposure to amphetamine increases incentive to obtain the drug: long-lasting effects revealed by the progressive ratio schedule. Behav Brain Res 107:9-19
24. Martin G, Ahmed SH, Blank T, Spiess J, Koob GF, Siggins GR (1999) Chronic morphine treatment alters NMDA receptor-mediated synaptic transmission in the nucleus accumbens. J Neurosci 19:9081-9089
25. Mello NK, Mendelson JH (1980) Buprenorphine suppresses heroin use by heroin addicts. Science 207:657-659
26. Mello NK, Negus SS (1998) The effects of buprenorphine on self-administration of cocaine and heroin "speedball" combinations and heroin alone by rhesus monkeys. J Pharmacol Exp Ther 285:444-456
27. Mello NK, Lukas SE, Kamien JB, Mendelson JH, Drieze J, Cone EJ (1992) The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J Pharmacol Exp Ther 260:1185-1193
28. Montoya ID, Gorelick DA, Preston KL, Schroeder JR, Umbricht A, Cheskin LJ, Lange WR, Contoreggi C, Johnson RE, Fudala PJ (2004) Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin Pharmacol Ther 75:34-48
29. Morgan D, Brebner K, Lynch WJ, Roberts DC (2002) Increases in the reinforcing efficacy of cocaine after particular histories of reinforcement. Behav Pharmacol 13:389-396
30. Negus SS (2006) Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone. J Pharmacol Exp Ther 317:711-723
31. Negus SS, Bidlack JM, Mello NK, Furness MS, Rice KC, Brandt MR (2002) Delta opioid antagonist effects of buprenorphine in rhesus monkeys. Behav Pharmacol 13:557-570
32. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, San Diego, CA
33. Rada P, Jensen K, Hoebel BG (2001) Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens. Psychopharmacology 157:105-110
34. Rady JJ, Holmes BB, Portoghese PS, Fujimoto JM (2000) Morphine tolerance in mice changes response of heroin from mu to delta opioid receptors. Proc Soc Exp Biol Med 224:93-101
35. Richardson NR, Gratton A (1996) Behavior-relevant changes in nucleus accumbens dopamine transmission elicited by food reinforcement: an electrochemical study in rat. J Neurosci 16:8160-8169
36. Roitman MF, Stuber GD, Phillips PE, Wightman RM, Carelli RM (2004) Dopamine operates as a subsecond modulator of food seeking. J Neurosci 24:1265-1271
37. Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR (1997) Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry 54:713-720
38. Schutz CG, Vlahov D, Anthony JC, Graham NM (1994) Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. J Clin Epidemiol 47:191-195
39. Shippenberg TS, Bals-Kubik R, Herz A (1987) Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes. Brain Res 436:234-239
40. Sorge RE, Rajabi H, Stewart J (2005) Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement. Neuropsychopharmacology 30:1681-1692
41. Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1996) Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index. J Clin Psychopharmacol 16:58-67
42. Vaccarino FJ, Bloom FE, Koob GF (1985) Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology 86:37-42
43. Vann RE, Balster RL, Beardsley PM (2006) Dose, duration, and pattern of nicotine administration as determinants of behavioral dependence in rats. Psychopharmacology 184:482-493
44. Ward SJ, Morgan D, Roberts DC (2005) Comparison of the reinforcing effects of cocaine and cocaine/heroin combinations under progressive ratio and choice schedules in rats. Neuropsychopharmacology 30:286-295
45. Winger G, Skjoldager P, Woods JH (1992) Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. J Pharmacol Exp Ther 261:311-317